文献速递衰弱、肌少症与跌倒老年慢病共病管理

长期阿司匹林使用与男性衰弱的关联:医师健康研究

Association Between Long-Term Aspirin Use and Frailty in Men: The Physicians' Health Study.
PubMed 文献 · J Gerontol A Biol Sci Med Sci · 2021-01-01

平均随访11±0.6年后,20%参与者衰弱;平均每年使用阿司匹林>60天者较≤60天者衰弱风险显著降低(OR 0.85, 95%CI 0.76-0.96)。

要点

  • 长期规律使用阿司匹林(>60天/年)与老年男性衰弱风险降低相关。
  • 该关联在多病共存和健康行为调整后仍存在。
  • 需进一步研究抗炎药物在衰老中的作用。

核心结论

  • 长期规律使用阿司匹林与老年男性衰弱呈负相关,即使考虑多病共存和健康行为后仍存在。

研究设计与样本

  • 通过年度问卷收集每日阿司匹林使用、生活方式和临床变量,平均使用天数分为≤60天/年和>60天/年两组。
  • 试验完成11年后使用33项衰弱指数评估衰弱,评分≥0.21定义为衰弱。
  • 采用倾向评分逆概率治疗加权控制混杂,逻辑回归模型估计衰弱比值比。

主要发现

  • 平均年龄70.5岁(范围60-101),平均随访11±0.6年。
  • 15%参与者报告阿司匹林使用≤60天/年;2413名参与者(20%)衰弱。
  • 阿司匹林使用频率与吸烟、饮酒、高血压和心血管疾病相关,与出血和华法林使用负相关。
  • 平均阿司匹林使用>60天/年 versus ≤60天/年,衰弱OR为0.85(95%CI 0.76-0.96)。
  • 使用替代衰弱定义结果相似。

关键数值与推荐

  • 衰弱评估采用33项衰弱指数,评分≥0.21定义为衰弱。
  • 阿司匹林平均使用分为≤60天/年和>60天/年两组。
  • 主要结局为衰弱,OR 0.85(95%CI 0.76-0.96)用于>60天/年 versus ≤60天/年。

临床怎么用

  • 对于老年男性,长期规律使用阿司匹林可能与较低衰弱风险相关,但需权衡出血风险。
  • 临床决策中应考虑多病共存和健康行为对衰弱的影响。
  • 抗炎药物对衰老的作用需进一步研究,不应仅基于此关联改变阿司匹林使用指征。

局限性

  • 研究为观察性分析,即使采用倾向评分加权仍可能存在残余混杂。
  • 阿司匹林使用为自我报告,可能存在测量误差。
  • 结果仅适用于男性,外推至女性需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic inflammation may lead to frailty, however the potential for anti-inflammatory medications such as aspirin to prevent frailty is unknown. We sought to examine the association between long-term aspirin use and prevalent frailty. METHODS: We included 12 101 men ≥60 years who participated in the Physicians' Health Study I, a completed aspirin randomized controlled trial (1982-1989). Annual questionnaires collected self-reported data on daily aspirin use, lifestyle, and clinical variables. Average aspirin use was summed into 2 categories: ≤60 days/year and >60 days/year. Frailty was assessed using a 33-item index 11 years after trial completion. A score of ≥0.21 was considered frail. Propensity score inverse probability of treatment weighting was used for statistical control of confounding. Logistic regression models estimated odds of frailty as a function of categories of average aspirin use. RESULTS: Mean age was 70.5 years (range 60-101). Following an average of 11 ± 0.6 years of follow-up, aspirin use was reported as ≤60 days/year for 15%; 2413 participants (20%) were frail. Frequency of aspirin use was associated with smoking, alcohol consumption, hypertension, and cardiovascular disease, but negatively associated with bleeding and Coumadin use. The odds ratio (95% confidence intervals) for frailty was 0.85 (0.76-0.96) for average aspirin use >60 days/year versus aspirin use ≤60 days/year. Results were similar using an alternate definition of frailty. CONCLUSIONS: Long-term regular aspirin use is inversely associated with frailty among older men, even after consideration of multimorbidity and health behaviors. Work is needed to understand the role of medications with anti-inflammatory properties on aging.

来源:J Gerontol A Biol Sci Med Sci,查看原文。版权归原作者所有。

引用

  1. Orkaby AR, Yang L, Dufour AB, et al. Association Between Long-Term Aspirin Use and Frailty in Men: The Physicians' Health Study. J Gerontol A Biol Sci Med Sci. 2021. PMID: 32918079. doi:10.1093/gerona/glaa233

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。